humeral fracture
Conditions
Interventions
Group RNS:Mixture of Esketamine and ropivacaine for brachial plexus block
Group RIS:Ropivacaine for brachial plexus block, intravenous Esketamine
Group R:Ropivacaine for brachial plexus block
Sponsors
Anhui Provincial Children's Hospital
Eligibility
Sex/Gender
All
Age
2 Years to 10 Years
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with humeral fracture before surgery and proposed to undergo open reduction; 2. Aged 2-10 years; 3. American Society of Anesthesiologists (ASA) Grades I to II; 4. Obtain the consent of the patient's family before surgery, and sign the informed consent; 5. No analgesics, hormones or any opioids were administered in the 24 hours prior to the operation.
Exclusion criteria
Exclusion criteria: 1. Local anesthetics allergy, puncture site damage, infection, abnormal coagulation function; 2. Allergic to esketamine; 3. Patients with peripheral neuropathy or injury; 4. Patients with severe kidney, liver, neurological or cardiovascular disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of analgesia; | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of sensory block;Duration of motor block;The concentrations of cortisol; | — |
Countries
China
Contacts
Public ContactLiu Junxia
Anhui Provincial Children's Hospital
Outcome results
None listed